Menu
Recruiting NCT04457544

Spontaneous Coronary Artery Dissection National Swiss Registry

Observational Spontaneous Coronary Artery Dissection

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Spontaneous Coronary Artery Dissection. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Switzerland
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Spontaneous Coronary Artery Dissection (SCAD) National Swiss Registry (SwissSCAD)

Overview

Spontaneous coronary artery dissection (SCAD), is an underdiagnosed pathology, affecting predominantly young women without traditional cardiovascular risk factors and is associated with major adverse outcomes including myocardial infarction, cardiac arrest, or death. Timely diagnosis of SCAD as well as clinical follow-up are of the essence in this pathology associated with major cardiac adverse outcomes. Despite recent improvements in diagnosis and recognition of the importance of SCAD, it remains poorly studied and understood. In this context, we designed the SwissSCAD registry, a large, observational, prospective, cohort study, to describe the natural history of SCAD, its outcomes and its treatments.

Primary outcome measures

  • Incidence of safety events at 30 days [Time frame: 30 days]
Secondary outcome measures (2)
  • Incidence of safety events at 1 year [Time frame: 1 year]
  • Incidence of safety events at 5 years [Time frame: 5 years]

Eligibility criteria

Inclusion criteria

  • Subject is ≥18 years of age.
  • Patient presenting newly diagnosed SCAD or diagnosed with SCAD within the last 5 years.
  • Subject must be willing to sign a Patient Informed Consent (PIC).

Exclusion criteria

  • Patient unwilling or unable to provide informed consent.
  • Patients with atherosclerotic or iatrogenic coronary dissection.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Study design

Observational model
Cohort

Study locations

Switzerland · 1 center
  • Geneva University Hospitals — Geneva

Identifiers

NCT: NCT04457544 · 2019-01886

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗